TIDMTRX

RNS Number : 5173K

Tissue Regenix Group PLC

05 January 2021

Tissue Regenix Group plc

Confirmation of Board appointments

Leeds, 5 January 2021 - Tissue Regenix Group (AIM:TRX) ("Tissue Regenix" or the "Group") the regenerative medical devices company, announces that, following the Group's announcement on 4 December 2020, Brian Phillips and Trevor Phillips have been appointed to the Board as independent Non-Executive Directors of Tissue Regenix.

Brian Phillips is now Chair of the Audit Committee and Trevor Phillips is Chair of the Remuneration Committee.

For more Information:

 
 Tissue Regenix Group plc                     Tel: 0330 430 3052 
  Caitlin Pearson Head of Communications 
------------------------------------------  -------------------- 
 
 Stifel Nicolaus Europe Limited (Nominated   Tel: 0207 710 7600 
  Adviser and Broker) 
  Ben Maddison / Alex Price 
------------------------------------------  --------------------

About Tissue Regenix

Tissue Regenix is a leading medical devices company in the field of regenerative medicine. The company's patented decellularisation ('dCELL(R)') technology removes DNA and other cellular material from animal and human soft tissue leaving an acellular tissue scaffold which is not rejected by the patient's body and can then be used to repair diseased or worn out body parts. Current applications address many critical clinical needs such as sports medicine, heart valve replacement and wound care.

In August 2017 Tissue Regenix acquired CellRight Technologies(R), a biotech company that specializes in regenerative medicine and is dedicated to the development of innovative osteoinductive and wound care scaffolds that enhance healing opportunities of defects created by trauma and disease. CellRight's human osteobiologics may be used in spine, trauma, general orthopaedic, foot & ankle, dental, and sports medicine surgical procedures.

Regulatory disclosures

Trevor Michael Phillips, 59, has been a director or partner of the following companies or partnerships during the past five years:

 
 Current directorships/partnerships   Directorships/partnerships 
                                       within the last 5 years 
 Prostratex Limited                   Vectura Group Investments Limited 
 NEPeSMO Limited                      hVIVO Limited 
                                      hVIVO Services Limited 
                                      Open Orphan plc 
                                      Morvus Technology Limited 
                                      Prep Biopharm Limited 
                                       Imutex Limited 
                                      Quadrant Drug Delivery Limited 
                                      QDose Limited 
                                      Quadrant Technologies Limited 
                                      Quadrant Healthcare Limited 
                                      Quadrant Holdings Cambridge 
                                       Limited 
                                      Quadrant Healthcare (UK) Limited 
                                      Quadrant Trustee Limited 
                                      Quadrant Bioresources Limited 
                                      Protosome Limited 
                                      Andaris Group Limited 
                                      Andaris (DDS) Limited 
                                      Microshot Limited 
                                      Innovata Biomed Limited 
                                      Innovata Limited 
                                      Vectura Group Services Limited

Trevor holds no shares in Tissue Regenix plc and there are no further disclosures required in accordance with AIM Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies.

George Brian Phillips, 60, has been a director or partner of the following companies or partnerships during the past five years:

 
 Current directorships/partnerships   Directorships/partnerships 
                                       within the last 5 years 
 NAHL Group plc                       Dig Space Limited 
 Muirfield Finance Limited            Tanygraig Limited 
 Muirfield Midco Limited              Preoday Limited 
 Muirfield Holdco Limited 
 Motocaddy Holdings Limited 
 Motocaddy Limited 
 Ethos Partners LLP 
 Imbiba Capital Limited 
 Imbiba (FP) LLP 
 Imbiba (GP) LLP 
 Imbiba Growth LLP 
 Purple Dragon (Holdings) Limited 
 Qikserve Limited 
 E&P Data Licensing Limited 
 The Jane Bubear Sport Foundation

Brian Phillips was a director of Valiant Sport Holdings Limited at the time it was placed into voluntary liquidation by members and creditors on 2 April 2013. The company was dissolved on 5 September 2014. There were no secured or preferential creditors. Unsecured creditors holding approximately GBP2.65m in aggregate received 0.7124p in pound.

Brian holds no shares in Tissue Regenix plc and there are no further disclosures required in accordance with AIM Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOAFLFFTLEISIIL

(END) Dow Jones Newswires

January 05, 2021 02:00 ET (07:00 GMT)

Tissue Regenix (LSE:TRX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Tissue Regenix Charts.
Tissue Regenix (LSE:TRX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Tissue Regenix Charts.